Bial vs DiaSorin S.p.A.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
Market cap history
● Bial● DiaSorin S.p.A.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Bial | DiaSorin S.p.A. DIA.MI · #3,935 in the world |
|---|---|---|
| Profile | ||
| Country | 🇵🇹 Portugal | 🇮🇹 Italy |
| Sector | Healthcare | Healthcare |
| Industry | — | Diagnostics and Research |
| Founded | 1924 | 2000 |
| Size | ||
| Market cap | — | $4.3 B |
| Revenue | — | $1.4 B |
| Net income | — | $185 M |
| Employees | — | 1,939 |
| Valuation | ||
| P/E ratio | — | 23.6× |
| Price to sales | — | 3.1× |
| Price to book | — | 2.3× |
| Free cash flow yield | — | 7.3% |
| Profitability | ||
| Gross margin | — | 64.7% |
| Operating margin | — | 19.1% |
| Net margin | — | 13.0% |
| Return on equity | — | 9.4% |
| Growth | ||
| Revenue growth | — | 5.0% |
| Earnings per share growth | — | -11.4% |
| Cash | ||
| Free cash flow margin | — | 23.5% |
| Altman Z-score zone | — | — |
| Data as of | Market cap — | Market cap Aug 2026; ratios FY2025 |